Fulminant capillary leak syndrome in a patient with systemic sclerosis treated with imatinib mesylate

Monique E. Hinchcliff; Jon Lomasney; Julie A. Johnson; John Varga

doi:10.1093/rheumatology/kew245

Fulminant capillary leak syndrome in a patient with systemic sclerosis treated with imatinib mesylate

Monique E. Hinchcliff^*, Jon Lomasney, Julie A. Johnson, John Varga

^*Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

4 Scopus citations

Original language	English (US)
Pages (from-to)	1916-1918
Number of pages	3
Journal	Rheumatology (United Kingdom)
Volume	55
Issue number	10
DOIs	https://doi.org/10.1093/rheumatology/kew245
State	Published - Oct 1 2016

ASJC Scopus subject areas

Rheumatology
Pharmacology (medical)

Access to Document

10.1093/rheumatology/kew245

Cite this

@article{32e5460973be49f9ba0f5fcdc78a7740,

title = "Fulminant capillary leak syndrome in a patient with systemic sclerosis treated with imatinib mesylate",

author = "Hinchcliff, {Monique E.} and Jon Lomasney and Johnson, {Julie A.} and John Varga",

note = "Funding Information: This work was supported by the National Institutes of Health [K23 AR059763, R21 AR068035 to M.H.); and the Scleroderma Research Foundation to M.H. Novartis funded the clinical trial but was not involved in the preparation of this correspondence. No specific funding was received from any bodies in the public, commercial or not-for-profit sectors to carry out the work described in this manuscript.",

year = "2016",

month = oct,

day = "1",

doi = "10.1093/rheumatology/kew245",

language = "English (US)",

volume = "55",

pages = "1916--1918",

journal = "Rheumatology and Rehabilitation",

issn = "1462-0324",

publisher = "Oxford University Press",

number = "10",

}

TY - JOUR

T1 - Fulminant capillary leak syndrome in a patient with systemic sclerosis treated with imatinib mesylate

AU - Hinchcliff, Monique E.

AU - Lomasney, Jon

AU - Johnson, Julie A.

AU - Varga, John

N1 - Funding Information: This work was supported by the National Institutes of Health [K23 AR059763, R21 AR068035 to M.H.); and the Scleroderma Research Foundation to M.H. Novartis funded the clinical trial but was not involved in the preparation of this correspondence. No specific funding was received from any bodies in the public, commercial or not-for-profit sectors to carry out the work described in this manuscript.

PY - 2016/10/1

Y1 - 2016/10/1

UR - http://www.scopus.com/inward/record.url?scp=84991051755&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84991051755&partnerID=8YFLogxK

U2 - 10.1093/rheumatology/kew245

DO - 10.1093/rheumatology/kew245

M3 - Letter

C2 - 27338086

AN - SCOPUS:84991051755

VL - 55

SP - 1916

EP - 1918

JO - Rheumatology and Rehabilitation

JF - Rheumatology and Rehabilitation

SN - 1462-0324

IS - 10

ER -

Fulminant capillary leak syndrome in a patient with systemic sclerosis treated with imatinib mesylate

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this